We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

95 hedge funds and large institutions have $626M invested in RAPT Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

90,075% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $16K

180% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 15

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

0.83% less ownership

Funds ownership: 12.63% → 11.8% (-0.83%)

3% less funds holding

Funds holding: 98 → 95 (-3)

9% less capital invested

Capital invested by funds: $691M → $626M (-$64.7M)

33% less funds holding in top 10

Funds holding in top 10: 9 → 6 (-3)

Holders
95
Holders Change
-3
Holders Change %
-3.06%
% of All Funds
1.53%
Holding in Top 10
6
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-33.33%
% of All Funds
0.1%
New
19
Increased
42
Reduced
15
Closed
17
Calls
$14.4M
Puts
$16K
Net Calls
+$14.4M
Net Calls Change
-$5.49M

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$26.1M
2
GPP
Great Point Partners
Connecticut
+$22.4M
3
State Street
State Street
Massachusetts
+$13.3M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.7M
5
Walleye Capital
Walleye Capital
New York
+$5.69M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$18.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$12.5M
3
Invesco
Invesco
Georgia
-$3.73M
4
BlackRock
BlackRock
New York
-$3.18M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.97M +$53.9K +337 +1%
LGM
27
Logos Global Management
California
$3.96M +$4M +25,000 New
Goldman Sachs
28
Goldman Sachs
New York
$3.92M +$641K +4,004 +19%
Charles Schwab
29
Charles Schwab
California
$3.39M +$93.9K +587 +3%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.89M +$1.5M +9,370 +105%
Bank of America
31
Bank of America
North Carolina
$2.84M +$1.88M +11,731 +190%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$2.72M +$12K +75 +0.4%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$2.51M +$545K +3,403 +27%
GTC
34
Ghost Tree Capital
New York
$2.48M +$700K +4,375 +39%
Los Angeles Capital Management
35
Los Angeles Capital Management
California
$2.4M +$2.18M +13,626 +901%
IHAM
36
Integral Health Asset Management
New York
$2.16M +$2.18M +13,625 New
UBS Group
37
UBS Group
Switzerland
$1.97M +$1.77M +11,029 +766%
TD Asset Management
38
TD Asset Management
Ontario, Canada
$1.85M -$57K -356 -3%
Citigroup
39
Citigroup
New York
$1.7M +$409K +2,557 +31%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$1.63M +$35.4K +221 +2%
Barclays
41
Barclays
United Kingdom
$1.58M +$693K +4,329 +77%
TOCUITCONY
42
Trustees of Columbia University in the City of New York
New York
$1.45M +$1.47M +9,173 New
CCMU
43
Cheyne Capital Management (UK)
United Kingdom
$1.42M +$1.44M +8,979 New
Swiss National Bank
44
Swiss National Bank
Switzerland
$1.37M +$260K +1,625 +23%
AG
45
Algert Global
California
$1.36M +$1.1M +6,872 +402%
Citadel Advisors
46
Citadel Advisors
Florida
$1.36M -$1.28M -7,972 -48%
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.18M -$2.88K -18 -0.2%
Thrivent Financial for Lutherans
48
Thrivent Financial for Lutherans
Minnesota
$1.17M +$1.19M +7,417 New
Millennium Management
49
Millennium Management
New York
$1.08M -$995K -6,215 -48%
JRP
50
Jasper Ridge Partners
California
$904K – – –
1
2
3 4 5

RAPT Hedge Fund Activity: Q4 2022 in Review

95 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2022, worth a combined $626M — down 9.4% from $691M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RAPT positions and 17 closed out — a net gain of 2 holders — while 42 added to existing stakes and 15 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $26.1M. The largest seller was Woodline Partners, cutting an estimated $18.9M.

  • 95 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2022, down from 98 in Q3 2022.
  • Funds reported $626M of RAPT Therapeutics stock for Q4 2022, down 9.4% quarter-over-quarter.
  • 19 funds opened new RAPT Therapeutics positions in Q4 2022 and 17 closed out, a net change of +2 holders.
  • The largest RAPT Therapeutics buyer in Q4 2022 was Deep Track Capital, an estimated $26.1M added.
  • The largest RAPT Therapeutics seller in Q4 2022 was Woodline Partners, an estimated $18.9M sold.

Based on aggregated 13F filings for Q4 2022.